## ACT: Enact Holdings, Inc. - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.7% in upper entry zone (3.0-6.0%), top 10% cross-sectional ranking. Short-term MRS_5 (4.2%) confirms momentum alignment. Strong momentum (+8.4% 5-day acceleration). Caution: overbought RSI (70).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($38.81)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 5 ($102.59M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 13.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Blackrock Inc.: 3.2% (+1.0%)
- Vanguard Group Inc: 2.2% (-2.0%)
- Dimensional Fund Adv: 1.9% (+7.1%)
- First Trust Advisors: 1.0% (+87.9%)
- Qube Research & Tech: 1.0% (+289.4%)

### Key Risks

1. Heavy insider selling: $103M sold (5 transactions in 90 days).
2. High short interest (16.2%, 12.6 days to cover): squeeze risk or crowded bearish bet.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Momentum building: MRS_10 improving +8.4% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

Forward P/E 8.7x stretched relative to 3% growth. Quality metrics strong (margin 54%). Balance sheet: strong liquidity (6612078000.0x), low leverage (D/E 0.29). Insider selling cluster ($102.6M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.9B |
| Beta | 0.52 |
| 52W Range | $30.79 - $40.38 |
| Short Interest | 16.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | N/A |
| Forward P/E | 8.7 |
| Current P/E | 9.0 |
| YoY Growth | 3.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -2.7% to 5.7% (+8.4% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 90th percentile. MRS_5 at 4.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 70, risk of mean reversion. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.74% (CS: 90) | Strong |
| RSI_14 | 70.1 | Overbought |
| MACD Histogram | 0.12 | Bullish |
| vs SMA20 | 1.046x | Above |
| vs SMA50 | 1.085x | Above |
| vs SMA200 | 1.110x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $40.27
- **Stop Loss:** $38.81 (3.6% risk)
- **Target:** $42.46 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 821
- **Position Value:** $33,061.67
- **Portfolio %:** 33.06%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-04 (Est: $1.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.11 | $1.12 | +0.9% |
| 2025Q2 | $1.11 | $1.15 | +3.9% |
| 2025Q1 | $1.09 | $1.10 | +0.9% |
| 2024Q4 | $1.08 | $1.09 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*